Total synthesis of natural (+)-FR900482. 1. Synthetic and end-game strategies

Tetrahedron Letters

Volumn 37, Issue 20, 1996, Pages 3471-3474

  Katoh, Tadashi ^a   Itoh, Etsuko ^a   Yoshino, Toshiharu ^a   Terashima, Shiro ^a  

^a SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 FORMYL 6,9 DIHYDROXY 14 OXA 1,11 DIAZATETRACYCLO[7.4.1.0 2,7 0 10,12]TETRADECA 2,4,6 TRIEN 8 YLMETHYLCARBAMATE; ANTINEOPLASTIC AGENT;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0029897093     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)00593-X     Document Type: Article

References (30)

1. a) Iwami, M., Kiyoto, S., Terano, H., Kohsaka, M., Aoki, H., Imanaka, H., J. Antibiot., 1987, 40, 589-593.
2. b) Kiyoto, S., Shibata, T., Yamashita, M., Komori, T., Okuhara, M., Terano, H., Kohsaka, M., Aoki, H., Imanaka, H., ibid., 1987, 40, 594-599.
3. a) Shimomura, K., Hirai, O., Mizota, T., Matsumoto, S., Mori, J., Shibayama, F., Kikuchi, H., J. Antibiot., 1987, 40, 600-606.
4. b) Hirai, O., Shimomura, K., Mizota, T., Matsumoto, S., Mori, J., Kikuchi, H., ibid., 1987, 40, 607-611.
5. FK973 (2) displays ca. three times more potent antitumor activities than 1 with a significant lower toxicity and has been used in Phase II of clinical trials, see, a) Shimomura, K., Manda, T., Mukumoto, S., Masuda, K., Nakamura, T., Mizota, T., Matsumoto, S., Nishigaki, F., Oku, T., Mori, J., Shibayama, F., Cancer Res., 1988, 48, 1166-1172.
6. b) Masuda, K., Nakamura, T., Mizota, T., Mori, J., Shimomura, K., ibid., 1988, 48, 5172-5177.
7. c) Masuda, K., Nakamura, T., Shimomura, K., Shibata, T., Terano, H., Kohsaka, M., J. Antibiot., 1988, 41, 1497-1499.
8. Uchida, I., Takase, S., Kayakiri, H., Kiyoto, S., Hashimoto, M., Tada, T., Koda, S., Morimoto, Y., J. Am. Chem. Soc., 1987, 40, 4108-4109.
9. For synthetic studies on 1 so far reported, see, a) Yasuda, N., Williams, R. M., Tetrahedron Lett., 1989, 30, 3397-3400.
10. b) Fukuyama, T., Goto, S., ibid., 1989, 30, 6491-6494.
11. c) Jones, R. J., Rapoport, H., J. Org. Chem., 1990, 55, 1144-1146.
12. d) McClure, K. F., Danishefsky, S. J., ibid., 1991, 56, 850-853.
13. e) McClure, K. F., Benbow, J. W., Danishefsky, S. J., Schulte, G. K., J. Am. Chem. Soc., 1991, 113, 8185-8186.
14. f) Dmitrienko, G. I., Denhart, D., Mithani, S., Prasad, G. K. B., Taylor, N. J., Tetrahedron Lett., 1992, 33, 5705-5708.
15. g) McClure, K. F., Danishefsky, S. J., J. Am. Chem. Soc., 1993, 115, 6094-6100.
16. h) McClure, K. F., Danishefsky, S. J., Schulte, G. K., J. Org. Chem., 1994, 59, 355-360.
17. i) Utsunomiya, I., Muratake, H., Natsume, M., Chem. Pharm. Bull., 1995, 43, 37-48.
18. j) Miller, S. J., Kim, S-H., Chen, Z-R., Grubbs, R. H., J. Am. Chem. Soc., 1995, 117, 2108-2109.
19. k) Martin, S. F., Wagman, A. S., Tetrahedron Lett., 1995, 36, 1169-1170.
20. Fukuyama, T., Xu, L., Goto, S., J. Am. Chem. Soc., 1992, 114, 383-385.
21. a) Schkeryantz, J. M., Danishefsky, S. J., J. Am. Chem. Soc., 1995, 117, 4722-4723.
22. b) Danishefsky, S. J., Schkeryantz, J. M., Synlett., 1995, 475-490.
23. a) Yoshino, T., Nagata, Y., Itoh, E., Hashimoto, M., Katoh, T., Terashima, S., Tetrahedron Lett., the accompanying paper.
24. b) Katoh, T., Yoshino, T., Nagata, Y., Nakatani, S., Terashima, S., ibid., the accompanying paper.
25. A large amount of 2 was kindly provided by Dr. H. Tanaka, Fujisawa Pharmaceutical Co. Ltd.
26. a) Ji, S., Gortler, L. B., Waring, A., Battisti, A., Bank, S., Closson, W. D., Wriede, P., J. Am. Chem. Soc., 1967, 89, 5311-5312.
27. b) Closson, W. D., Ji, S., Schulenberg, S., ibid., 1970, 92, 650-657.
28. For recent examples in the cleavage of N-Ts-amides by the use of sodium naphthalenide, see, a) McIntosh, J. M., Matassa, L. C., J. Org. Chem., 1988, 53, 4452-4457.
29. b) Heathcock, C. H., Blumenkopf, T. A., Smith, K. M., ibid., 1989, 54, 1548-1562.
30. c) Ban, Y., Nakajima, S., Yoshida, K., Mori, M., Shibasaki, M., Heterocycles, 1994, 39, 657-667.